INBX Inhibrx Biosciences

Watchlist

Trading Jun 17 14:49 ET

205.41MMarket Cap-1247P/E (TTM)

Inhibrx Biosciences Key Stats

Currency: USD

Period

Q1 FY2024 Earnings

Revenue(YoY)

0.00

0.00%

EPS(YoY)

-3.46

-24.39%

Analyst Rating

Hold

May 31, 2024

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q3	-- / 0.000	--
--	2024/Q2	-- / 0.000	--
--	2024/Q1	0.000 / 0.000	--
--	2023/Q4	1.634M / 50.000K	--
--	2023/Q3	119.000K / 0.000	--
--	2023/Q2	30.000K / 0.000	--
--	2023/Q1	17.000K / 100.000K	--
--	2022/Q4	274.000K / 793.330K	--
--	2022/Q3	278.000K / 566.670K	--
--	2022/Q2	711.000K / 1.070M	--